Page last updated: 2024-08-21

violacein and Acute Promyelocytic Leukemia

violacein has been researched along with Acute Promyelocytic Leukemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bos, CL; DurĂ¡n, N; Ferreira, CV; Justo, GZ; Peppelenbosch, MP; Versteeg, HH1

Other Studies

1 other study(ies) available for violacein and Acute Promyelocytic Leukemia

ArticleYear
Molecular mechanism of violacein-mediated human leukemia cell death.
    Blood, 2004, Sep-01, Volume: 104, Issue:5

    Topics: Antigens, CD; Caspase 3; Caspases; Cell Death; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA-Binding Proteins; HL-60 Cells; Humans; Indoles; K562 Cells; Leukemia, Promyelocytic, Acute; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; NF-kappa B; Phosphorylation; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Signal Transduction; STAT1 Transcription Factor; STAT2 Transcription Factor; Trans-Activators; U937 Cells; Up-Regulation

2004